Thu, February 5, 2009
[ Thu, Feb 05th 2009 ] - Market Wire
GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast
[ Thu, Feb 05th 2009 ] - Market Wire
BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B
[ Thu, Feb 05th 2009 ] - Market Wire
Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing
[ Thu, Feb 05th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference
[ Thu, Feb 05th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean
[ Thu, Feb 05th 2009 ] - Market Wire
Illumina Presents Development Roadmap for Scaling its Genome Analyzer
[ Thu, Feb 05th 2009 ] - Market Wire
Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference
Wed, February 4, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn
[ Wed, Feb 04th 2009 ] - Market Wire
NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Toxin Alert Inc.: Andersen Resigns From Toxin Alert Board
[ Wed, Feb 04th 2009 ] - Market Wire
Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares
[ Wed, Feb 04th 2009 ] - Market Wire
Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of
[ Wed, Feb 04th 2009 ] - Market Wire
Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry
[ Wed, Feb 04th 2009 ] - Market Wire
Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices
[ Wed, Feb 04th 2009 ] - Market Wire
Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
Progenics Appoints Peter J. Crowley as Independent Board Member
[ Wed, Feb 04th 2009 ] - Market Wire
UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards
[ Wed, Feb 04th 2009 ] - Market Wire
EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening
[ Wed, Feb 04th 2009 ] - Market Wire
Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System
[ Wed, Feb 04th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf
[ Wed, Feb 04th 2009 ] - Market Wire
MEDNAX, Inc. Acquires Neonatal Practice
[ Wed, Feb 04th 2009 ] - Market Wire
Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11
[ Wed, Feb 04th 2009 ] - Market Wire
Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures
Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
[ Tue, Feb 03rd 2009 ] - Market Wire
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development
[ Tue, Feb 03rd 2009 ] - Market Wire
Affymax to Present at BIO CEO and Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
[ Tue, Feb 03rd 2009 ] - Market Wire
PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
[ Tue, Feb 03rd 2009 ] - Market Wire
Amarin to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Amedisys Acquires Two Home Health Agencies in Arizona
[ Tue, Feb 03rd 2009 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.
[ Tue, Feb 03rd 2009 ] - Market Wire
Inspire Announces Webcast of Presentation at BIO CEO Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement
[ Tue, Feb 03rd 2009 ] - Market Wire
Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Market Wire
Kindred Healthcare to Present at the UBS Global Healthcare Services Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
LHC Group and Ochsner Health System Complete Home Health Joint Venture
[ Mon, Feb 02nd 2009 ] - Market Wire
Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in
[ Mon, Feb 02nd 2009 ] - Market Wire
Ligand Announces Phase IIb Results With DARA
[ Mon, Feb 02nd 2009 ] - Market Wire
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
[ Mon, Feb 02nd 2009 ] - Market Wire
Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call
[ Mon, Feb 02nd 2009 ] - Market Wire
Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia
[ Mon, Feb 02nd 2009 ] - Market Wire
ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma
[ Mon, Feb 02nd 2009 ] - Market Wire
Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital
[ Mon, Feb 02nd 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)
[ Mon, Feb 02nd 2009 ] - Market Wire
Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®
[ Mon, Feb 02nd 2009 ] - Market Wire
Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment
[ Mon, Feb 02nd 2009 ] - Market Wire
Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S
[ Mon, Feb 02nd 2009 ] - Market Wire
LifePoint Hospitals Acquires Rockdale Medical Center
[ Mon, Feb 02nd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in
[ Mon, Feb 02nd 2009 ] - Market Wire
ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results
Sun, February 1, 2009
[ Sun, Feb 01st 2009 ] - Market Wire
FORTIS: Fortis holding announcement
Sat, January 31, 2009
[ Sat, Jan 31st 2009 ] - Market Wire
FORTIS: Fortis holding publishes addendum to shareholder circular
[ Sat, Jan 31st 2009 ] - Market Wire
Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification
[ Fri, Jan 30th 2009 ] - Market Wire
Teva Announces Approval of Generic Risperdal® Oral Solution
[ Fri, Jan 30th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer
[ Fri, Jan 30th 2009 ] - Market Wire
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
[ Fri, Jan 30th 2009 ] - Market Wire
DexCom Announces Pricing of Public Offering of Common Stock
[ Fri, Jan 30th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference
[ Fri, Jan 30th 2009 ] - Market Wire
GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry
[ Fri, Jan 30th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
[ Fri, Jan 30th 2009 ] - Market Wire
St. Jude Medical Announces 2009 Annual Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
SonoSite Introduces Powerful New Turbo Technology for S Series"
[ Fri, Jan 30th 2009 ] - Market Wire
GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame
[ Fri, Jan 30th 2009 ] - Market Wire
Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time
[ Fri, Jan 30th 2009 ] - Market Wire
REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us
[ Fri, Jan 30th 2009 ] - Market Wire
Santarus Submits New Drug Application for ZEGERID Tablet Product
Thu, January 29, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
EXACT Sciences Regains NASDAQ Compliance
[ Thu, Jan 29th 2009 ] - Market Wire
CompCare Acquires Core Corporate Consulting Group, Inc.
[ Thu, Jan 29th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast
[ Thu, Jan 29th 2009 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $125,000 to North Carolina Non-Profits
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $857,500 to Non-Profits in Florida
[ Thu, Jan 29th 2009 ] - Market Wire
Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria
[ Thu, Jan 29th 2009 ] - Market Wire
Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
[ Thu, Jan 29th 2009 ] - Market Wire
Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009
[ Thu, Jan 29th 2009 ] - Market Wire
Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program
[ Thu, Jan 29th 2009 ] - Market Wire
Data from Columbia Laboratories? Study for the Pr .. be Presented at the Society for Maternal-Fetal Me
[ Thu, Jan 29th 2009 ] - Market Wire
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results
[ Thu, Jan 29th 2009 ] - Market Wire
University of Texas at Austin Acquires SOLiD System to Advance Genomic Research
[ Thu, Jan 29th 2009 ] - Market Wire
Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
[ Thu, Jan 29th 2009 ] - Market Wire
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
[ Thu, Jan 29th 2009 ] - Market Wire
Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17
[ Thu, Jan 29th 2009 ] - Market Wire
POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint
[ Thu, Jan 29th 2009 ] - Market Wire
Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5
Wed, January 28, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Enzon Nominates Two New Candidates for Its Board of Directors
[ Wed, Jan 28th 2009 ] - Market Wire
Aetna Announces 2009 Annual Meeting Details
[ Wed, Jan 28th 2009 ] - Market Wire
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
[ Wed, Jan 28th 2009 ] - Market Wire
Sepracor Announces Strategic Corporate Restructur .. ction Plan in Addition to 2009 Financial Guidance
[ Wed, Jan 28th 2009 ] - Market Wire
Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner
[ Wed, Jan 28th 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call
[ Wed, Jan 28th 2009 ] - Market Wire
Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office
[ Wed, Jan 28th 2009 ] - Market Wire
Resumen: Gilead esboza las prioridades de I+D para 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt
[ Wed, Jan 28th 2009 ] - Market Wire
Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25
[ Wed, Jan 28th 2009 ] - Market Wire
VIVUS Announces Senior Management Promotions
[ Wed, Jan 28th 2009 ] - Market Wire
Geron Announces John Walker Resigns as Director
[ Wed, Jan 28th 2009 ] - Market Wire
Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
[ Wed, Jan 28th 2009 ] - Market Wire
Medtronic Expands CURE-AF Clinical Program into Europe and Canada
[ Wed, Jan 28th 2009 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating
[ Wed, Jan 28th 2009 ] - Market Wire
ZymoGenetics Secures Worldwide Rights to IL-21
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
Skilled Healthcare to Announce 2008 Fourth Quarter & Full Year Results
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group/PacifiCare Awards More Than $5 .. Grants to Help Improve Health Care in California
[ Tue, Jan 27th 2009 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences Announces Update to Shareholders
[ Tue, Jan 27th 2009 ] - Market Wire
Pioneer Behavioral Health: PHC Sets Fiscal Second .. ence Call for Friday, February 13 at 10:00 a.m. E
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group?s Evercare Business Awarded for Innovation in Coordinated Care
[ Tue, Jan 27th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Inc. Engages Investor Relations Group
[ Tue, Jan 27th 2009 ] - Market Wire
Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash
[ Tue, Jan 27th 2009 ] - Market Wire
Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months
[ Tue, Jan 27th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Appo .. pher J. Schaber, PhD, to BioNJ Board of Directors
[ Tue, Jan 27th 2009 ] - Market Wire
Alnylam Promotes Akshay Vaishnaw to Senior Vice President, Clinical Research
[ Tue, Jan 27th 2009 ] - Market Wire
St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results
[ Tue, Jan 27th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific Adds Midwest Sales Representative
[ Tue, Jan 27th 2009 ] - Market Wire
Sequenom Commences Exchange Offer to Acquire EXACT Sciences
[ Tue, Jan 27th 2009 ] - Market Wire
PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split
[ Tue, Jan 27th 2009 ] - Market Wire
Inspire Initiates Phase 3 Prolacria" Dry Eye Trial under Special Protocol Assessment Agreement
[ Tue, Jan 27th 2009 ] - Market Wire
Illumina Launches Suite of Next-Generation Sequencing Kits
[ Tue, Jan 27th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Onyx Pha .. wfield Exploration, D.R. Horton, KB Home and MGIC
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months
[ Mon, Jan 26th 2009 ] - jason scholder
First Stem Cell Study For Spinal Injury Approved. New Hope For Back Pain Sufferers Worldwide.
[ Mon, Jan 26th 2009 ] - Market Wire
Theravance, Inc.: Theravance Submits U.S. NDA for .. for the Treatment of Hospital-Acquired Pneumonia
[ Mon, Jan 26th 2009 ] - Market Wire
HealthSpring to Webcast Its Investor Day on February 27, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
PhotoMedex Announces Results of Stockholders? Meeting
[ Mon, Jan 26th 2009 ] - Market Wire
DelSite, Inc.: DelSite, Inc. Discontinues Manufac .. DA Approval to Initiate Phase I Clinical Study fo
[ Mon, Jan 26th 2009 ] - Market Wire
Mannatech Launches Economic Stimulus Plan for Business Builders
[ Mon, Jan 26th 2009 ] - Market Wire
Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United States and Europe
[ Mon, Jan 26th 2009 ] - Market Wire
Altus Pharmaceuticals Realigns Product Developmen .. on Long-Acting Growth Hormone Candidate ALTU-238
[ Mon, Jan 26th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Form .. Acute Radiation Enteritis Medical Advisory Board
[ Mon, Jan 26th 2009 ] - Market Wire
Endurance Athletes Get High-Quality Results with Low-Cal Accelerade Hydro and Endurox Restore
[ Mon, Jan 26th 2009 ] - Market Wire
St. Jude Medical Announces European CE Mark Appro .. Brain Stimulation Systems for Parkinson?s Disease
[ Mon, Jan 26th 2009 ] - Market Wire
Collaboration Between RXi Pharmaceuticals and the .. Medical School Receives a Massachusetts Life Scie
[ Mon, Jan 26th 2009 ] - Market Wire
MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer
[ Mon, Jan 26th 2009 ] - Market Wire
MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York
[ Mon, Jan 26th 2009 ] - Market Wire
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
[ Mon, Jan 26th 2009 ] - Market Wire
WellCare Files 2007 Annual Report on Form 10-K
[ Mon, Jan 26th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: WellPoin .. tech, Green Mountain Coffee, Peet's and Starbucks
Sun, January 25, 2009
[ Sun, Jan 25th 2009 ] - Market Wire
Crucell N.V.: Discussions on a Combination of Crucell and Wyeth Discontinued
[ Sun, Jan 25th 2009 ] - Marc Woodard
Heal Back Pain Without Surgery - Embryonic Stem Cell Update!
Fri, January 23, 2009
[ Fri, Jan 23rd 2009 ] - Market Wire
Alcon Placed for the 11th Consecutive Year on FOR .. agazine?s List of 100 Best Companies to Work For?
[ Fri, Jan 23rd 2009 ] - Market Wire
Advanced Viral Research Corp.: Advanced Viral Ann .. f Operations Due to Inability to Secure Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Urologix to Host Its Fiscal 2009 Second Quarter Conference Call
[ Fri, Jan 23rd 2009 ] - Market Wire
NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock
[ Fri, Jan 23rd 2009 ] - Market Wire
Sepracor Inc. Sets Conference Call and Webcast fo .. urth Quarter and Full-Year 2008 Operating Results
[ Fri, Jan 23rd 2009 ] - Market Wire
ImClone Systems and Bristol-Myers Squibb Update t .. ung Cancer Supplemental Biologics Application Sub
[ Fri, Jan 23rd 2009 ] - Market Wire
CLX Medical, Inc.: CLX Medical, Inc. Issues CEO C .. ith Ownership and Planned Distribution of FDA Cle
[ Fri, Jan 23rd 2009 ] - Market Wire
International Stem Cell Receives Second $1M Tranche Under $5 Million Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Alnylam Receives Clearance from FDA to Initiate P .. y with ALN-VSP for the Treatment of Liver Cancers
[ Fri, Jan 23rd 2009 ] - Market Wire
Hollis-Eden Researchers Present New Findings on M .. ancer Drug Candidate APOPTONE" (HE3235) at Americ
[ Fri, Jan 23rd 2009 ] - Market Wire
GTx Announces Conference Call to Discuss EMEA Label Changes to Fareston®
[ Fri, Jan 23rd 2009 ] - Market Wire
Centene Corporation?s Georgia Subsidiary Receives Prestigious NCQA Accreditation
[ Fri, Jan 23rd 2009 ] - Market Wire
Zacks Bull and Bear of the Day Highlights: Abbott Labs, Hubbell, Wipro, Citigroup and Infosys
Thu, January 22, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. ings Release Date for Thursday, February 12, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Cubist Pharmaceuticals Reports GAAP Diluted Net I .. ourth Quarter 2008 and GAAP Diluted Net Income of
[ Thu, Jan 22nd 2009 ] - Market Wire
OPKO Health Initiates Clinical Trial of the Aquashunt" to Treat Glaucoma
[ Thu, Jan 22nd 2009 ] - Market Wire
Proton Laboratories Inc.: Transparency - Sales - .. ton Laboratories Building on Years of Development
[ Thu, Jan 22nd 2009 ] - Market Wire
Bard to Host Earnings Conference Call on January 29, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Midland Exploration Inc.: New Drill Program on Midland Exporation's Maritime Cadillac Property
[ Thu, Jan 22nd 2009 ] - Market Wire
LifeVantage Names Network Marketing Expert Randal Wojta as Master Distributor for the Company
[ Thu, Jan 22nd 2009 ] - Market Wire
Simon Stevens Appointed Executive Vice President .. terprise-Wide Health Care Reform Engagement; Will
[ Thu, Jan 22nd 2009 ] - Market Wire
RXi Pharmaceuticals Appoints Rudolph Nisi, M.D. to Board of Directors
[ Thu, Jan 22nd 2009 ] - Market Wire
Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing
[ Thu, Jan 22nd 2009 ] - Market Wire
ZOLL Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
OR-Live, Inc.: REMINDER: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration
[ Thu, Jan 22nd 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Rece .. Design Contract for Controlled Environment System
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Preliminary Results for Fourth Quarter and Full Year 2008
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Exchange Offer for up to $1.6 Bil .. egate Principal Amount of Notes Due 2011 and 2012
[ Thu, Jan 22nd 2009 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. Second Quarter Fiscal Year 2009 Financial Results
[ Thu, Jan 22nd 2009 ] - Market Wire
BioDelivery Sciences Files Shelf Registration
Wed, January 21, 2009
[ Wed, Jan 21st 2009 ] - Market Wire
Cobalis Corp. Enters into a Master Broker Agreeme .. MDC to Help Launch PreHistin into Global Markets
[ Wed, Jan 21st 2009 ] - Market Wire
Medistem Inc.: Medistem Files Form 15
[ Wed, Jan 21st 2009 ] - Market Wire
Sernova Corp.: Sernova Corp.: Resignation of Just .. dent Board of Directors Initiates Internal Review
[ Wed, Jan 21st 2009 ] - Market Wire
Enzon Concludes Tender Offer for a Portion of Its Debt
[ Wed, Jan 21st 2009 ] - Market Wire
Molina Healthcare Provides More Definitive 2008 G .. dance within Company?s Previously Announced Range

Schaeffer's Street Stories: Eli Lilly & Co. Slips as Drug Sales Slow


//health-fitness.news-articles.net/content/2009/ .. ories-eli-lilly-co-slips-as-drug-sales-slow.html
Published in Health and Fitness on Thursday, January 29th 2009 at 12:23 GMT, Last Modified on 2009-01-29 12:23:29 by Market Wire   Print publication without navigation


CINCINNATI--([ BUSINESS WIRE ])--Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) announced this morning that it suffered a fourth-quarter net loss as it booked a $4.73 billion charge for its November acquisition of ImClone Systems, while sales were roughly flat with a year earlier. The company posted a quarterly loss of $3.63 billion, or $3.31 per share, versus its year-ago loss of $854.4 million, or 78 cents per share. Excluding the ImClone charge and other items, earnings rose 19% to $1.07 per share. Net sales rose less than 1% to $5.21 billion, with international sales down 3% and domestic revenue up 3%.

Analysts had predicted a profit of $1.05 per share on revenue of $5.42 billion.

To continue reading this article, click here: [ http://www.schaeffersresearch.com/commentary/content/eli+lilly+co+slips+as+drug+sales+slow/observations.aspx?click=home&ID=90840 ]


Publication Contributing Sources